July 16, 2007
Prospector
Profile
07.1053
 
Global Biotech Corporation NAICS 312112
3810 St. Patrick Suite 2D Montreal, Quebec H4E 1A4 Description Bottled Water Mfg.
(514) 935-8589 Employees 0
Revenue (mil) 0.0000
  Income (mil) -0.0470
  Assets (mil) 0.3940
  Liability (mil) 0.6070
  (for the year ended 2006-11-30)
 
Category: Audit Concerns
 
Event: Chang G. Park CPA raised substantial doubt about the ability of Global Biotech Corporation to continue as a going concern after auditing its financial statements. The auditor notes that the Company generated net losses of $47,203 for the year ended November 30, 2006 and a net loss of $846,255during the period from November 2, 1998 through November 30, 2006. At November 30, 2006 the Company had negative working capital of $213,026 and a stockholders 'deficit of $213,026.
 
Intellectual Property: On August 26, 2005, the Company finalized an agreement with Advanced Fluid Technologies to purchase their patent pending oxygenation unit and all technical know how, intellectual properties, methodologies and all information pertaining to the fixation of the oxygen molecule to water or any other fluid and/or to the building and maintenance of the oxygenation unit. The Company also acquired all trademarks for the name Aquaboost Oxygenated Water, currently in force in the U.S., Canada and Mexico and the right to use and register the name globally. [SEC Filing 10-KSB 06-19-07]
 
Description: The Company's goal is to position AquaBoost™, the bottled oxygenated water product it expects to acquire from Advanced Fluid Technologies, as an energizing alternative to soft drinks and as a beverage with more health benefits than ordinary water.
 
Officers: Louis Greco (Pres. & Dir.); Perry Choiniere (COO & Dir.); Jean Pierre Robichaud (VP & Dir.); Dr. Pierre Marois (Chief Scientific Officer & Dir.); Eric Sonigo (VP)
 
Auditor: Chang G. Park CPA
 
Securities: 49,265,500 common shares outstanding as of November 30, 2006.
 
 
 
return to main page